Can a bleeding drug speed up breast reduction recovery?
NCT ID NCT07131592
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether tranexamic acid (TXA), a drug that reduces bleeding, can decrease fluid drainage after breast reduction surgery. 160 adults having bilateral breast reduction will be randomly assigned to receive IV TXA or not, and each breast will get either TXA or saline through the drain. The goal is to see if TXA reduces drainage volume and shortens the time drains need to stay in, potentially improving recovery.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- tranexamic acid (TXA)
- What this could lead to
- If it works, this could lead to faster drain removal and fewer complications after breast reduction surgery.
- What could go wrong
- This is a small, early-phase study focused on recovery after a routine surgery, not a major disease. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST REDUCTIONS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital
RECRUITINGBoston, Massachusetts, 02114, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.